psalexa
logo

Proteomics Market

Global Proteomics Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS11099
Available Format:
Category : Biotechnology

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Instrumentation Technology

1.3.2. Market Segmentation by Reagents

1.3.3. Market Segmentation by Services and Software

1.3.4. Market Segmentation by Application

1.3.5. Market Segmentation by Geography

1.3.6. Analysis Period

1.3.7. Market Data Reporting Unit

1.3.7.1. Value

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents

2.2.1.1. By region

2.2.1.2. By industry participants

2.2.1.3. By company type

2.3. Market Size Estimation

2.4. Market Breakdown and Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Market Segmentation

4.1.1. Overview by Instrumentation Technology

4.1.1.1. Protein microarrays

4.1.1.1.1. Biochips

4.1.1.1.1.1. Protein chips

4.1.1.1.1.2. Lab-on-chips

4.1.1.1.2. Microarray instruments

4.1.1.1.2.1. Integrated systems

4.1.1.1.2.2. Arrayers

4.1.1.1.2.3. Microarray scanners

4.1.1.2. Spectroscopy

4.1.1.2.1. Mass spectrometry

4.1.1.2.2. Nmr spectroscopy

4.1.1.2.3. Circular dichroism (cd) spectroscopy

4.1.1.3. X-ray crystallography

4.1.1.4. Chromatography

4.1.1.4.1. HPLC systems

4.1.1.4.2. Ion chromatography

4.1.1.4.3. Affinity chromatography

4.1.1.4.4. Supercritical fluid chromatography

4.1.1.5. Electrophoresis

4.1.1.5.1. Gel electrophoresis

4.1.1.5.2. Capillary electrophoresis

4.1.1.6. Surface plasmon resonance (SPR) systems

4.1.1.7. Protein fractionation systems

4.1.2. Overview by Reagent

4.1.2.1. Microarray reagents

4.1.2.2. Spectroscopy reagents

4.1.2.3. X-ray crystallography reagents

4.1.2.4. Chromatography reagents

4.1.2.5. Electrophoresis reagents

4.1.2.6. Immunoassay reagents

4.1.2.7. Protein fractionation reagents

4.1.3. Overview by Services & Software

4.1.3.1. Analytical laboratory services

4.1.3.1.1. Protein identification

4.1.3.1.2. Protein separation

4.1.3.1.3. Protein sequencing

4.1.3.2. Data analysis & maintenance

4.1.3.2.1. Bioinformatics databases

4.1.3.2.2. Bioinformatics tools

4.1.3.3. Quantitation services

4.1.4. Overview by Application

4.1.4.1. Drug discovery

4.1.4.2. Clinical diagnosis

4.1.4.3. Others

4.2. Market Dynamics

4.2.1. Trends

4.2.2. Drivers

4.2.2.1. Impact analysis of drivers on market forecast

4.2.3. Restraints

4.2.3.1. Impact analysis of restraints on market forecast

4.2.4. Opportunities

4.3. Porter’s Five Forces Analysis

Chapter 5. Market Size and Forecast by Instrumentation Technology

5.1. Protein Microarrays

5.1.1. Biochips

5.1.1.1. Protein chips

5.1.1.2. Lab-on chips

5.1.2. Microarray Instruments

5.1.2.1. Integrated systems

5.1.2.2. Arrayers

5.1.2.3. Microarray scanners

5.2. Spectroscopy

5.2.1. Mass Spectroscopy

5.2.2. NMR Spectroscopy

5.2.3. Circular Dichroism (CD) Spectroscopy

5.3. X-Ray crystallography

5.4. Chromatography

5.4.1. HPLC Systems

5.4.2. Ion Chromatography

5.4.3. Affinity Chromatography

5.4.4. Supercritical Fluid Chromatography

5.5. Electrophoresis

5.5.1. Gel Electrophoresis

5.5.2. Capillary Electrophoresis

5.6. Surface Plasmon Resonance Systems

5.7. Protein Fractionation Systems

Chapter 6. Market Size and Forecast by Reagents

6.1. Microarray Reagents

6.2. Spectroscopy Reagents

6.3. X-ray Crystallography Reagents

6.4. Chromatography Reagents

6.5. Electrophoresis Reagents

6.6. Immunoassay Reagents

6.7. Protein Fractionation Reagents

Chapter 7. Market Size and Forecast by Services & Software

7.1. Analytical Laboratory Services

7.1.1. Protein Identification

7.1.2. Protein Separation

7.1.3. Protein Sequencing

7.2. Data Analysis & Maintenance

7.2.1. Bioinformatics Databases

7.2.2. Bioinformatics Tools

7.3. Quantitation Services

Chapter 8. Market Size and Forecast by Application

8.1. Drug Discovery

8.2. Clinical Diagnosis

Chapter 9. Market Size and Forecast by Geography

9.1. North America Proteomics Market

9.1.1. By Instrumentation Technology

9.1.2. By Reagents

9.1.3. By Services & Software

9.1.4. By Application

9.1.5. By Country – The U.S. and Canada

9.2. Europe Proteomics Market

9.2.1. By Instrumentation Technology

9.2.2. By Reagents

9.2.3. By Services & Software

9.2.4. By Application

9.2.5. By Country – Germany, the U.K., France, Italy, Spain and Rest of Europe

9.3. Asia-Pacific Proteomics Market

9.3.1. By Instrumentation Technology

9.3.2. By Reagents

9.3.3. By Services & Software

9.3.4. By Application

9.3.5. By Country –China, India, Japan, and Rest of Asia-Pacific

9.4. Latin America Proteomics Market

9.4.1. By Instrumentation Technology

9.4.2. By Reagents

9.4.3. By Services & Software

9.4.4. By Application

9.4.5. By Country – Brazil, Mexico and Rest of Latin America

9.5. Middle East & Africa (MEA) Proteomics Market

9.5.1. By Instrumentation Technology

9.5.2. By Reagents

9.5.3. By Services & Software

9.5.4. By Application

9.5.5. By Country – South Africa, Saudi Arabia and Rest of MEA

Chapter 10. Competitive Landscape

10.1. Competitive Benchmarking of Key Players

10.2. Global Strategic Developments

Chapter 11. Company Profiles

11.1. Agilent Technologies Inc.

11.1.1. Business Overview

11.1.2. Product and Service Offerings

11.1.3. Key Financial Summary

11.1.4. Strategic Growth Plan

11.2. Bruker Corporation

11.2.1. Business Overview

11.2.2. Product and Service Offerings

11.2.3. Key Financial Summary

11.2.4. Strategic Growth Plan

11.3. GE Healthcare

11.3.1. Business Overview

11.3.2. Product and Service Offerings

11.3.3. Key Financial Summary

11.3.4. Strategic Growth Plan

11.4. Merck KGaA

11.4.1. Business Overview

11.4.2. Product and Service Offerings

11.4.3. Key Financial Summary

11.4.4. Strategic Growth Plan

11.5. Thermo Fisher Scientific, Inc.

11.5.1. Business Overview

11.5.2. Product and Service Offerings

11.5.3. Key Financial Summary

11.5.4. Strategic Growth Plan

11.6. Bio-Rad Laboratories, Inc.

11.6.1. Business Overview

11.6.2. Product and Service Offerings

11.6.3. Key Financial Summary

11.6.4. Strategic Growth Plan

11.7. Waters Corporation

11.7.1. Business Overview

11.7.2. Product and Service Offerings

11.7.3. Key Financial Summary

11.7.4. Strategic Growth Plan

11.8. Danaher Corporation

11.8.1. Business Overview

11.8.2. Product and Service Offerings

11.8.3. Key Financial Summary

11.8.4. Strategic Growth Plan

11.9. Luminex Corporation

11.9.1. Business Overview

11.9.2. Product and Service Offerings

11.9.3. Key Financial Summary

11.9.4. Strategic Growth Plan

11.10. PerkinElmer Inc.

11.10.1. Business Overview

11.10.2. Product and Service Offerings

11.10.3. Key Financial Summary

11.10.4. Strategic Growth Plan

*Note: Key financial summary and strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.

Chapter 12. Appendix

12.1. Abbreviations

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry